Status of vaccine candidates as of December 19. The Oxford-AstraZeneca vaccine is expected to be the most affordable. Two were approved as of the date of the chart—Pfizer and Moderna. |
We are all waiting for the vaccine that will allow us to escape from the twilight zone of Covid-19 life.
While Americans have started to roll out the Pfizer and Moderna vaccines, most of the world is looking to the Oxford-AstraZeneca vaccine.
It will be sold at cost in poorer countries and does not require ultra-low refrigeration, just normal refrigeration levels.
The Guardian has just produced an illuminating walk-through of the process by which the Oxford vaccine has been generated in double-quick time. It should be a source of pride for any Oxonian.
The Oxford vaccine is expected to be approved in the UK shortly after Christmas. Here is The Lancet's review of the trials so far.
No comments:
Post a Comment